Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B Read More »
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.
Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development Read More »
La eficiencia de un motor de combustión interna en el sector agroindustrial no es el resultado de la fortuna, sino de un equilibrio termodinámico preciso entre los fluidos que lo recorren y su grado de pureza. En este ecosistema de alta ingeniería, los filtros para tra …
The insurer has been overhauling its executive bench as it attempts to bolster flagging profits in health benefits and capitalize on growth in Carelon, including through six new appointments on Tuesday.
Elevance fills slew of mid-level leadership positions Read More »
Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.
Medtronic to study renal denervation combined with PCI Read More »
The revamp comes nearly two years after the department under the Biden administration first restructured the HHS’ technology functions.
HHS reverses Biden-era tech reorganization, returns ONC name Read More »
Durante los últimos años, el modelo agrivoltaico ha ido ganando protagonismo en el panorama energético europeo, con aplicaciones que van desde los cultivos tradicionales hasta el pastoreo o la apicultura. A este avance se suma la incorporación de tecnologí …
Agrivoltaica inteligente: cultivando el futuro de la energía solar Read More »
Whoop, the maker of a wearable wristband, plans to use the funds for global expansion and personalized health features.
Whoop raises $575M, adds Abbott as strategic investor Read More »
The company designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.
Medtronic wins CE mark for OmniaSecure defibrillation lead Read More »
PepGen’s lead candidate for myotonic dystrophy type 1 barely beat the placebo in a Phase 2 trial in terms of fixing incorrect gene splicing, but the biotech attributed the poor result to an outlier.
PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease Read More »
